Free Trial

Kiniksa Pharmaceuticals International (KNSA) Earnings Date, Estimates & Call Transcripts

Kiniksa Pharmaceuticals International logo
$28.09 -0.86 (-2.97%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$28.24 +0.15 (+0.52%)
As of 07/11/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kiniksa Pharmaceuticals International Earnings Summary

Kiniksa Pharmaceuticals International posted Q1 2025 earnings on April 29, 2025, reporting an EPS of $0.11, which beat the consensus estimate of $0.02 by $0.09. Quarterly revenue rose 72.5% year-over-year to $137.79 million, above the consensus estimate of $128.35 million. With a trailing EPS of -$0.25, Kiniksa Pharmaceuticals International's earnings are expected to grow next year, from ($0.55) to $0.25 per share.

Upcoming Q2
Earnings Date
Jul. 22Before Market OpensEstimated
Consensus EPS
(Apr. 29)
$0.02
Actual EPS
(Apr. 29)
$0.11 Beat By $0.09
Actual Revenue
(Apr. 29)
$137.79M

Q1 2025 Earnings Resources

KNSA Upcoming Earnings

Kiniksa Pharmaceuticals International's Q2 2025 earnings is scheduled for Tuesday, July 22, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Kiniksa Pharmaceuticals International Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kiniksa Pharmaceuticals International and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

KNSA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KNSA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kiniksa Pharmaceuticals International Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20251$0.31$0.31$0.31
Q2 20251$0.24$0.24$0.24
Q3 20251$0.25$0.25$0.25
Q4 20251$0.28$0.28$0.28
FY 2025 4 $1.08 $1.08 $1.08
Q1 20261$0.31$0.31$0.31
Q2 20261$0.35$0.35$0.35
Q3 20261$0.39$0.39$0.39
Q4 20261$0.42$0.42$0.42

Kiniksa Pharmaceuticals International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/22/2025
(Estimated)
-------
4/29/2025Q1 2025$0.02$0.11+$0.09$0.11$128.35M$137.79M
2/25/2025Q4 2024-$0.06-$0.12 -$0.06-$0.12$123.42M$122.50M
10/29/2024Q3 2024-$0.01-$0.18 -$0.17-$0.18$111.51M$112.21M
7/23/2024Q2 2024-$0.09-$0.06+$0.03-$0.06$90.60M$108.30M
4/23/2024Q1 2024-$0.14-$0.25 -$0.11-$0.25$76.97M$79.90M
2/28/2024Q4 2023-$0.11$0.04+$0.15-$0.27$72.31M$83.40M
10/31/2023Q3 2023-$0.18-$0.20 -$0.02-$0.20$62.53M$67.05M
7/25/2023Q2 2023-$0.16-$0.02+$0.14-$0.25$52.33M$71.47M

Kiniksa Pharmaceuticals International Earnings - Frequently Asked Questions

Kiniksa Pharmaceuticals International has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 22nd, 2025 based off last year's report dates. Learn more on KNSA's earnings history.

Kiniksa Pharmaceuticals International updated its FY 2025 earnings guidance on Tuesday, April, 29th. The company issued revenue guidance of $590.0 million-$605.0 million, compared to the consensus revenue estimate of $577.6 million.

In the previous quarter, Kiniksa Pharmaceuticals International (NASDAQ:KNSA) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.09. Learn more on analysts' earnings estimate vs. KNSA's actual earnings.

The conference call for Kiniksa Pharmaceuticals International's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Kiniksa Pharmaceuticals International's latest earnings report can be read online.
Read Transcript

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) has a recorded annual revenue of $423.24 million.

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) has a recorded net income of -$43.19 million. KNSA has generated -$0.25 earnings per share over the last four quarters.

Kiniksa Pharmaceuticals International's earnings are expected to grow from ($0.55) per share to $0.25 per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:KNSA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners